Tabula Rasa is led by a diverse yet cohesive board of directors, who share a commitment to improving lives and to advancing the goals and objectives of our companies.The Board is comprised of members drawn from careers in business, healthcare, finance, academia, and public service. They determine our strategies and policies, and are dedicated to serving the interests of our company and our shareholders.
Calvin H. Knowlton
CEO, Chairman and Founder
Tabula Rasa HealthCare
Calvin H. Knowlton, BScPharm, MDiv, PhD, is the Founder, CEO and Chairman of Tabula Rasa Healthcare. He is the Founder of ten companies, including CareKinesis, the first national Medication Risk Mitigation company dedicated to PACE (Programs of All-inclusive Care for the Elderly), and excelleRx/Hospice Pharmacia. Dr. Knowlton has received numerous awards for his leadership in pharmacy, business, and philanthropy. He is a recipient of the 2015 Remington Honor Medal, Pharmacy’s Highest Award, presented by American Pharmacists Association (APhA) and was named named the Most Influential US Pharmacist in 1997. Dr. Knowlton has served as the national President for the American College of Apothecaries; President of the APhA for two terms; and President of the APhA Foundation. He is a member of the APhA Pharmacogenomics Task Force, as well as the FDA-recognized National Pharmacogenomics Advisory Group.
Orsula V. Knowlton
President & Chief Marketing/New Business Development Officer
Tabula Rasa HealthCare
Orsula Voltis Knowlton, PharmD, MBA, is Co-founder, President and Chief Marketing/New Business Development Officer of Tabula Rasa HealthCare (TRHC). Prior to TRHC, Dr. Knowlton was a key member of the start-up management team of excelleRx, a hospice medication management and pharmacy distribution company. During her tenure as Vice President, Chief Marketing, Strategy, and Business Development Officer, from 1995 through 2007, the company grew organically to service more than 85,000 hospice patients in 49 States. Dr. Knowlton was named a “Woman of Distinction” 2006 by the Philadelphia Business Journal; “NJ’s Best 50 Women in Business 2008” by NJBIZ; winner of NJ Garden State Entrepreneur Excellence Award 2013 and SNJ Business People “Exceptional Entrepreneurs Award” 2014.
Samira K. Beckwith
President & CEO
Samira K. Beckwith has served as the President and CEO of Hope Healthcare for more than 25 years. She serves on the Board of Directors for the Florida Center for Nursing under appointment from Governor Rick Scott and previously served on former Governor Jeb Bush’s Long-Term Care Advisory Committee. Dr. Beckwith was appointed to the White House Conference on Aging and participated in US Senate Special Committee on Aging. She has served as Chair for both the National Hospice and Palliative Care Organization and the National Hospice Foundation. In addition, she is the Founding President of the Florida PACE Association and a Founding Director of the National Hospice Work Group.
Founder, President & CEO
Health Intelligence Partners
Jan Berger, MD, MJ, is the Founder, President and CEO of Health Intelligence Partners, a global healthcare consultancy that advises clients on areas of growth. She previously served as Senior Vice President, Chief Clinical Officer and Innovation Officer for CVS Health/Caremark and as Chief Clinical Strategist for Quantum Health. Dr. Berger has served on a number of healthcare and consumer product boards and currently serves on the Board of Directors of Cambia Health Solutions, Accentcare, Inc. and GNS Healthcare. She is an Assistant Professor at Northwestern University’s School of Medicine and School of Communication.
Dennis K. Helling
Executive Director Emeritus, Pharmacy
Kaiser Permanente, Colorado
Dennis K. Helling, PharmD, ScD (Hon), FCCP, FASHP, FAPhA is the Executive Director Emeritus, Pharmacy Operations & Therapeutics, Kaiser Permanente Colorado and Clinical Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Helling served Kaiser from 1992-2013. He was a Founding Member and President of the American College of Clinical Pharmacy. He also served as President of the Accreditation Council for Pharmacy Education and the American Pharmacists Association Foundation. Dr. Helling has been actively involved in hospice and palliative care for many years, serving on the Board of Directors of Care Synergy and as Vice-Chair of the The Denver Hospice Board of Directors. He currently serves on the American Pharmacists Association Board of Trustees and the Board of Pharmacy Specialties Board of Directors.
Vice President/General Manager, Skin & Marketing Services
Kathy O’Brien is Vice President of Skin and Marketing Services for Unilever North America overseeing a portfolio of brands including Dove, Caress, Suave, and Vaseline. She previously served as Unilever’s Vice President and General Manager of Foods in the United States, with responsibility for brands like Ragú, Skippy, Slim-fast and Wishbone. In 2012, Ms. O’Brien was honored as a Top Woman in Grocery by Progressive Grocer Magazine. She was named one of Advertising Age’s 25 Women to Watch in 2010. Ms. O’Brien is on the Board of Directors of the Network of Executive Women (NEW) and Cosmetic Executive Women and is a member of the Board of Trustees of Lehigh Valley Health Network.
Audit Partner (retired)
Deloitte & Touche, LLP
Michael Purcell served as an audit partner at Deloitte & Touche for 36 years, providing assurance and advisory services to public and private enterprise clients. He was the Philadelphia Office leader of Deloitte’s middle-market and growth enterprise services. He has assisted many emerging companies over the years including successful initial public offerings and exit transactions. He currently serves as a consultant for several venture funds. Mr. Purcell has served on the Board of Directors and Audit Committee of numerous for-profit entities including Capital Funding Bancorp, McKean Defense Group, Code 3 Emergency Partners, and Intermex.
A. Gordon Tunstall
President & Founder
A. Gordon Tunstall is the Founder of Tunstall Consulting, recognized as one of the most successful, national consulting firms specializing in providing entrepreneurs with business strategy development and access to the institutional financial marketplace. He had a pivotal role in TRHC’s IPO process, his 38th IPO. Featured in Forbes, The Wall Street Journal and other national publications, Mr. Tunstall has been honored as Ernst & Young’s Entrepreneur of the Year for his dual successes as the founder of Tunstall Consulting and his efforts in supporting entrepreneurship.